Aobiome Therapeuticsincis A Life Sciences Company Located In Cambridgemassachusettsfounded In 2013 By Jamie Heywood And David Whitlockthe Company Specializes In Developing Microbiome Based Therapies Aimed At Treating A Variety Of Inflammatory Conditionsincluding Skinnasaland Systemic Diseases Aobiome S Product Pipeline Features Several Clinical Stage Programsthese Include Studies For Treating Acne Vulgarishypertensioneczemamigrainerosaceaand Allergic Rhinitisutilizing A Specific Strain Of Ammonia Oxidizing Bacteria To Enhance Skin Health And Manage Inflammationthe Company Also Has Preclinical Programs Targeting Additional Inflammatory Indicationsaobiome Is Dedicated To Advancing Innovative Treatments That Leverage The Human Microbiome
